Yelena Krupitskaya

Ramucirumab, a fully human mAb to the transmembrane signaling tyrosine kinase VEGFR-2 for the potential treatment of cancer.

Yelena Krupitskaya, Heather A. Wakelee · PubMed · 2009 · 99 citations

Medicine, Oncology, Pharmacology +17

Osteoblastic Bone Flare on F18-FDG PET in Non-small Cell Lung Cancer (NSCLC) Patients Receiving Bevacizumab in Addition to Standard Chemotherapy

Yelena Krupitskaya, Hedieh K. Eslamy, Dorothy Nguyen et al. · Journal of Thoracic Oncology · 2009 · 42 citations · Full text

Medicine, Oncology, Chemotherapy +16

A Phase II First-Line Study of Gemcitabine, Carboplatin, and Bevacizumab in Advanced Stage Nonsquamous Non-small Cell Lung Cancer

Christelle Clément-Duchêne, Yelena Krupitskaya, Kristen N. Ganjoo et al. · Journal of Thoracic Oncology · 2010 · 16 citations · Full text

Medicine, Oncology, Pharmacology +10

A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer

Christelle Clément-Duchêne, Ronald B. Natale, Thierry Jahan et al. · Lung Cancer · 2012 · 13 citations · Full text

Medicine, Oncology, Pharmacology +13